Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Cardiff Oncology (CRDF) Debt Ratio (2016 - 2020)

Cardiff Oncology's Debt Ratio history spans 7 years, with the latest figure at 0.01 for Q2 2020.

  • For Q2 2020, Debt Ratio changed N/A year-over-year to 0.01; the TTM value through Jun 2020 reached 0.01, changed N/A, while the annual FY2017 figure was 0.11, 71.19% down from the prior year.
  • Debt Ratio for Q2 2020 was 0.01 at Cardiff Oncology, down from 0.11 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.49 in Q1 2017 and bottomed at 0.01 in Q2 2020.
  • The 4-year median for Debt Ratio is 0.19 (2016), against an average of 0.22.
  • The largest annual shift saw Debt Ratio soared 98.77% in 2017 before it crashed 76.89% in 2018.
  • A 4-year view of Debt Ratio shows it stood at 0.38 in 2016, then crashed by 71.19% to 0.11 in 2017, then increased by 4.15% to 0.11 in 2018, then crashed by 93.11% to 0.01 in 2020.
  • Per Business Quant, the three most recent readings for CRDF's Debt Ratio are 0.01 (Q2 2020), 0.11 (Q1 2018), and 0.11 (Q4 2017).